Danaher Corporation (DHR) Net Profit Margin: 14.89%
Is Danaher Corporation’s net profit margin high or low?
Danaher Corporation's net profit margin of 14.89% is 23% below its 5-year average of 19.37%, near the low end of its 5-year range (14.71%–27.06%).
The net profit margin for Danaher Corporation (DHR) is 14.89% as of Wednesday, June 10, 2026. It is below its 12-month average by 4.06% (15.52%).
DHR Net Profit Margin Chart
DHR Average Net Profit Margin Chart
DHR Current vs Average Net Profit Margin Chart
DHR Net Profit Margin Metrics
NET PROFIT MARGIN
14.89%
NET PROFIT MARGIN AVG TTM
15.52%
NET PROFIT MARGIN AVG 3Y
19.51%
NET PROFIT MARGIN AVG 5Y
19.37%
NET PROFIT MARGIN AVG 10Y
17.53%
NET PROFIT MARGIN AVG 15Y
16.15%
NET PROFIT MARGIN AVG 20Y
14.91%
CURRENT VS TTM AVG
-4.06%
CURRENT VS 3Y AVG
-23.68%
CURRENT VS 5Y AVG
-23.14%
CURRENT VS 10Y AVG
-15.04%
CURRENT VS 15Y AVG
-7.79%
CURRENT VS 20Y AVG
-0.11%
DHR Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | — | 14.89% | 15.52% | 19.51% | 19.37% |
| CVS Health Corporation (CVS) | $125.16B | 0.72% | 0.84% | 1.34% | 1.79% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 15.01% | -1.95% | 6.91% | 3.59% |
| Pfizer Inc. (PFE) | $146.36B | 11.83% | 12.51% | 14.97% | 18.18% |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 28.15% | 28.09% | 25.67% | 26.14% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 35.40% | 13.94% | 25.44% | 29.40% |
| Gilead Sciences, Inc. (GILD) | $151.21B | 30.99% | 15.29% | 17.07% | 15.27% |
| Abbott Laboratories (ABT) | $154.66B | 13.91% | 23.34% | 19.20% | 17.71% |
| Medtronic plc (MDT) | $103.04B | 13.20% | 13.55% | 12.62% | 13.06% |
| Elevance Health Inc. (ELV) | $87.43B | 2.62% | 3.11% | 3.37% | 3.60% |
Margin Comparison
Operating Margin
20.9%
Net Profit Margin
14.9%
Danaher Corporation Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation Net Profit Margin FAQ
- What is the net profit margin for Danaher Corporation (DHR)?
- The net profit margin for DHR stock is 14.89%.
- Is Danaher Corporation's net profit margin high or low?
- Danaher Corporation's net profit margin of 14.89% is 23% below its 5-year average of 19.37%, near the low end of its 5-year range (14.71%–27.06%).
- What is the TTM average net profit margin for Danaher Corporation (DHR)?
- The TTM average net profit margin for DHR stock is 15.52%.
- What is the 3Y average net profit margin for Danaher Corporation (DHR)?
- The 3Y average net profit margin for DHR stock is 19.51%.
- What is the 5Y average net profit margin for Danaher Corporation (DHR)?
- The 5Y average net profit margin for DHR stock is 19.37%.
- What is the 10Y average net profit margin for Danaher Corporation (DHR)?
- The 10Y average net profit margin for DHR stock is 17.53%.
- What is the 15Y average net profit margin for Danaher Corporation (DHR)?
- The 15Y average net profit margin for DHR stock is 16.15%.
- What is the 20Y average net profit margin for Danaher Corporation (DHR)?
- The 20Y average net profit margin for DHR stock is 14.91%.
Danaher Corporation Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 14.71% |
| 2024-12-31 | 16.33% |
| 2023-12-31 | 19.94% |
| 2022-12-31 | 27.06% |
| 2021-12-31 | 21.84% |
| 2020-12-31 | 16.36% |
| 2019-12-31 | 14.28% |
| 2018-12-31 | 15.55% |
| 2017-12-31 | 13.60% |
| 2016-12-31 | 15.13% |
| 2015-12-31 | 17.99% |
| 2014-12-31 | 13.05% |
| 2013-12-31 | 14.10% |
| 2012-12-31 | 12.59% |
| 2011-12-31 | 12.25% |
| 2010-12-31 | 13.58% |
| 2009-12-31 | 10.30% |
| 2008-12-31 | 10.38% |
| 2007-12-31 | 11.07% |
| 2006-12-31 | 11.69% |
| 2005-12-31 | 11.24% |
| 2004-12-31 | 10.83% |
| 2003-12-31 | 10.14% |
| 2002-12-31 | 6.34% |
| 2001-12-31 | 7.87% |
| 2000-12-31 | 8.58% |
| 1999-12-31 | 8.18% |
| 1998-12-31 | 6.29% |
| 1997-12-31 | 7.55% |
| 1996-12-31 | 11.47% |
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair